Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion type Assertion NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_head.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion description "[We, therefore, treated a panel of established glioma cell lines, including EGFR overexpressors, and primary cultures derived from patients diagnosed with glioblastoma with the JAK/STAT inhibitor cucurbitacin-I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_provenance.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion evidence source_evidence_literature NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_provenance.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion SIO_000772 25482928 NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_provenance.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion wasDerivedFrom befree-2016 NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_provenance.
- NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_assertion wasGeneratedBy ECO_0000203 NP1245656.RAr1V4zTvoThO8Ib7PpFWlXpTPGxmDfluT8J1c6j8t1ZM130_provenance.